Synthesis and evaluation of the antiproliferative activity of new heterylmethylidene derivatives of imidazothiazolotriazinones

Two novel series of 6-heterylmethylidenetetrahydroimidazo[4,5-e]thiazolo[3,2-b]-1,2,4-triazine-2,7(1H,6H)-diones and 7-heterylmethylidenetetrahydroimidazo[4,5-e]thiazolo[2,3-c]-1,2,4-triazine-2,8(3H,7H)-diones were synthesized by aldol condensation of tetrahydroimidazo[4,5-e]thiazolo[3,2-b]-1,2,4-triazine-2,7(1H,6H)-dione hydrobromides with heteroaromatic aldehydes and subsequent skeletal rearrangement of the thiazolotriazine fragment. The antiproliferative activity of the synthesized compounds was evaluated. Among the derivatives, (Z)-1,3-diethyl-7-[(1H-indol-3-yl)methylidene]-1,3a,4,9a-tetrahydroimidazo[4,5-e]thiazolo[2,3-c]-1,2,4-triazine-2,8(3H,7H)-dione 4n exhibited the highest antiproliferative activity. The GI(50) values of the compound against 24 of the 60 cancer cell lines were < 10 nM; against 32 of the 60 cell lines, they were 11.5-63.2 nM; and the GI(50) values against the remaining 4 cell lines were 1.33-6.38 mu M. Experiments with annexin showed that compound 4n induced apoptosis and necrosis in Jurkat cells (acute T cell leukemia).

Automated summary

Two novel series of compounds were synthesized and evaluated for their antiproliferative activity, with one compound showing high potency with very low GI(50) values against a subset of cancer cell lines among 60 tested.